Latest News
- June 21, 2024First patient randomized in a Phase 1 study for a China based Biotech Company
- May 28, 2024IND application submitted by CBCC
- May 17, 2024We are exhibiting at BIO 2024! Come visit our booth #4952
- May 16, 2024Let’s connect at 2024 ASCO annual meeting!
- May 09, 2024Successful completion of 9 USFDA inspections
Webinar: Overview of the 505(b)(2) regulatory pathway for NDA
Keen on learning best practices, seize opportunities, and overcome challenges linked to IND submissions for products which fall under the 505(b)(2) regulatory pathway?
Access to the latest webinar on:
Overview of the 505(b)(2) regulatory pathway for NDA
Webinar Link: https://www.youtube.com/watch?v=dXW5UA9TFKA
Speakers:
Dr. Sandeep Singh (VP – Clinical Operations & Regulatory Affairs, CBCC Global Research)
Ankit Parikh (Senior Manager – Medical Writing & Regulatory Affairs, CBCC Global Research)
Moderator:
Manoj Bharathi (Director – Corporate Development, CBCC Global Research)
In this webinar, our expert will cover the unique components and customizations involved in 505(b)(2) IND submissions and study requirements.
You will learn:
Underlying common bottlenecks, regulatory requirements, as well as mitigating risk while charting out plans to stay ahead of timelines.